TABLE 3.
Pharmacological Subgroups most frequently involved in unknown adverse drug reactions.
| Chemical, pharmacological or therapeutic subgroup | N | % |
|---|---|---|
| Vaccines (J07) | 68 | 21,3 |
| Antineoplastic agents (l01) | 39 | 12,2 |
| Immunosuppressants (L04) | 35 | 11 |
| Antibacterials for systemic use (J01) | 21 | 6,6 |
| Antiepileptics (N03) | 15 | 4,7 |
| Antithrombotic agents (B01) | 13 | 4,1 |
| Antiprotozoals (P01) | 12 | 3,8 |
| Analgesics (N02) | 10 | 3,1 |
| Antivirals for systemic use (J05) | 9 | 2,8 |
| Anesthetics (N01) | 7 | 2,2 |
| Corticosteroids for systemic use (H02) | 6 | 1,9 |
| Drugs used in diabetes (A10) | 6 | 1,9 |
| Diuretics (C03) | 5 | 1,6 |
| Drugs for acid related disorders (A02) | 5 | 1,6 |
| Drugs for obstructive airway diseases (R03) | 5 | 1,6 |
| Sex hormones and modulators of the genital system (G03) | 5 | 1,6 |
| Antihypertensives (C02) | 4 | 1,3 |
| Beta blocking agents (C07) | 4 | 1,3 |
| Drugs for functional gastrointestinal disorders (A03) | 4 | 1,3 |
| Pituitary and hypothalamic hormones and analogues (H01) | 4 | 1,3 |
| All other therapeutic products (V03) | 3 | 0,9 |
| Antiemetics and antinauseants (A04) | 3 | 0,9 |
| Calcium channel blockers (C08) | 3 | 0,9 |
| Cardiac therapy (C01) | 3 | 0,9 |
| Psychoanaleptics (N06) | 3 | 0,9 |
| Psycholeptics (N05) | 3 | 0,9 |
| Others a | 24 | 7,4 |
| Total | 319 | 100 |
a
Frequency ≤ 2.